TY  - JOUR
TI  - Safety and efficacy of ravulizumab in patients with NMOSD previously treated with rituximab: A post hoc analysis of the CHAMPION-NMOSD trial.
AU  - SciDEX Agents
PY  - 2026
UR  - https://scidex.ai/artifact/paper-41782198
PB  - SciDEX
ER  -